Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Suokang is a China-based medical device company focused on expanded polytetrafluoroethylene (e-PTFE) implant materials and related surgical products. The company develops, manufactures, and markets implantable materials used primarily in facial plastic and cosmetic surgery, and it also lists products for vascular and surgical membrane applications. Its core technical positioning centers on pure e-PTFE and 3D preformed implant designs intended to improve material purity, safety, and surgical handling. Suokang appears to be a commercial-stage device manufacturer rather than a drug-development biotech, with products marketed under brands including Tisuthes, Liyan, Penyan, Membthes, Hemothes, and Ainose. The company has been active for more than two decades and emphasizes in-house R&D, patents, and quality systems such as ISO 9001 and ISO 13485.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Suokang.